Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-22

Clinical Trial Update: (ACTH) for the Treatment of Sarcoid Uveitis

View source ↗

Summary

An update on a clinical trial evaluating adrenocorticotropic hormone (ACTH) for sarcoidosis-associated uveitis; no results or status details are provided in the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACTH (adrenocorticotropic hormone)

Snippet

Sponsor: John Huang, MD | Conditions: Sarcoid Uveitis | Status: UNKNOWN